Wall Street’s five-week winning streak came to an end, with the S & P 500 losing 0.42% for the week, while the Dow Jones Industrial Average...
The third quarter was a turning point, yanking us out of an earnings recession that put up three straight quarters of negative growth. Supply chains loosened...
Jim Cramer ran through all 35 stocks in his Charitable Trust portfolio on Wednesday during the November edition of the CNBC Investing Club’s Monthly Meeting. Source:...
Wall Street pulled back this week as investors focused more on higher bond yields, tensions in the Middle East, and energy price dynamics than they did...
Here’s our Club Mailbag email [email protected] — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing...
CHICAGO, ILLINOIS – MAY 05: Bausch + Lomb eye vitamins are offered for sale at a drug store on May 05, 2022 in Chicago, Illinois. Bausch...
Johnson & Johnson (JNJ) — an iconic, 136-year-old American enterprise — will soon reshape itself, separating its division that makes Tylenol, Band-Aids, and other consumer health...
The CNBC Investing Club held the March edition of its Monthly Meeting on Tuesday, and Jim Cramer ran through all 36 stocks in the Club’s portfolio....
Here’s a rapid-fire update on all 34 stocks in Jim Cramer’s Charitable Trust, the holdings we manage in the CNBC Investing Club. Jim and Club portfolio...
Virtually every corner of the stock market had a horrible 2022, including initial public offerings. The Renaissance IPO ETF (IPO) , which tracks the performance of...